Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy
MEDS Public Health and Preventive Medicine · 2022
DOI: 10.23977/phpm.2022.020311 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Public Health and Preventive Medicine, 2022.
Abstract (Originalsprache)
Diabetic peripheral neuropathy has a serious impact on the health and quality of life of patients. At present, the disease is mainly treated by aldose reductase inhibitors and other drugs. These drugs can effectively relieve the clinical symptoms of patients, and have good improvement effect on their neurological function, which can delay the development of the disease to a large extent. In clinical treatment, for the treatment of the disease, mainly in the premise of stable control of blood sugar, give patients the corresponding drug adjuvant treatment. In this paper, on the basis of consulting the relevant literature, we analyzed the progress of drug treatment of patients.
Zitieren
APA
(2022). Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy. MEDS Public Health and Preventive Medicine. https://doi.org/10.23977/phpm.2022.020311
Vancouver
Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy. MEDS Public Health and Preventive Medicine. 2022. doi:10.23977/phpm.2022.020311
BibTeX
@article{euvimed2022,
title = {Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy},
journal = {MEDS Public Health and Preventive Medicine},
year = {2022},
doi = {10.23977/phpm.2022.020311}
}
EUVIMED